Tuberculosis and HIV: Implications in the developing world

被引：18

作者：

Charles M. ^{[1
]}

Pape J.W. ^{[1
]}

机构：

[1] Division of International Medicine and Infectious Diseases, Weill Medical College of Cornell University, New York, NY 10021, 1330 York Avenue

来源：

Current HIV/AIDS Reports | 2006年 / 3卷 / 3期

关键词：

Tuberculosis; Isoniazid; Tuberculin Skin Test; Rifabutin; Sputum Smear;

D O I：

10.1007/BF02696658

中图分类号：

学科分类号：

摘要：

Developing countries bear the brunt of the epidemics of AIDS and tuberculosis (TB), and the management of patients with both diseases poses a particular challenge in these settings. In this article, we review implications for the twin epidemics of HIV and TB for the developing world with respect to diagnosis, prevention, treatment and integration of national TB and HIV programs. Copyright © 2006 by Current Science Inc.

引用

页码：139 / 144

页数：5

共 32 条

[1]

Corbett E.L., HIV and tuberculosis: Surveillance revisited, Int J Tuberc Lung Dis, 7, (2003)

[2]

Joint United Nations Programme on HIV/AIDS/World Health Organization: AIDS Epidemic Update: December 2005

[3]

Lewis D.K., Whitty C.J., Walsh A.L., Et al., Treatable factors associated with severe anaemia in adults admitted to medical wards in Blantyre, Malawi, an area of high HIV seroprevalence, Trans R Soc Trop Med Hyg, 99, pp. 561-567, (2005)

[4]

Burgess A.L., Fitzgerald D.W., Severe P., Et al., Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti, AIDS, 15, pp. 1875-1879, (2001)

[5]

Mazurek G.H., Jereb J., Lobeue P., Et al., Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States, MMWR Recomm Rep, 54, pp. 49-55, (2005)

[6]

Pape J.W., Jean S.S., Ho J.L., Et al., Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection, Lancet, 342, pp. 268-272, (1993)

[7]

Woldehanna S., Volmink J., Treatment of latent tuberculosis infection in HIV infected persons, Cochrane Database Syst Rev, (2004)

[8]

Jindani A., Nunn A.J., Enarson D.A., Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: International multicentre randomised trial, Lancet, 364, pp. 1244-1251, (2004)

[9]

Fitzgerald D.W., Desvarieux M., Severe P., Et al., Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: A randomised trial, Lancet, 356, pp. 1470-1474, (2000)

[10]

Perriens J.H., St Louis M.E., Mukadi Y.B., Et al., Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months, N Engl J Med, 332, pp. 779-784, (1995)

← 1 2 3 4 →